Nathan Wlodarchak

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 3

Top Topics

Molecular Dynamics Simulations

Acinetobacter Baumannii

Mycobacterium Tuberculosis

Top Venues

PLoS computational biology

Molecular pharmaceutics

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Nathan Wlodarchak, John B Feltenberger, Zhengqing Ye, Jeffrey Beczkiewicz, Rebecca Procknow, Gang Yan, Troy M King, Jennifer E Golden, Robert Striker
Engineering Selectivity for Reduced Toxicity of Bacterial Kinase Inhibitors Using Structure-Guided Medicinal Chemistry. ACS medicinal chemistry letters 12 (2) (2021)
Huikun Zhang, Spencer S Ericksen, Ching-Pei Lee, Gene E Ananiev, Nathan Wlodarchak, Peng Yu, Julie C Mitchell, Anthony Gitter, Stephen J Wright, F Michael Hoffmann, Scott A Wildman, Michael A Newton
Predicting kinase inhibitors using bioactivity matrix derived informer sets. PLoS computational biology 15 (8) (2019)
Nathan Wlodarchak, Nathan Teachout, Jeffrey Beczkiewicz, Rebecca Procknow, Adam J Schaenzer, Kenneth Satyshur, Martin Pavelka, William J Zuercher, David Drewry, John-Demian Sauer, Robert Striker
In Silico Screen and Structural Analysis Identifies Bacterial Kinase Inhibitors which Act with β-Lactams To Inhibit Mycobacterial Growth. Molecular pharmaceutics 15 (11) (2018)